Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AB Biotek HNH is a specialized life sciences division of AB Mauri, a global leader in yeast and fermentation technologies and a subsidiary of Associated British Foods. The company focuses on the development and commercialization of science-based ingredients for the human nutrition and health market, including probiotics, postbiotics, and specialty yeast products. Their portfolio is designed to address key health concerns such as immune support, digestive wellness, and metabolic health through advanced fermentation processes. AB Biotek HNH operates as a B2B provider, offering both proprietary branded ingredients and customized fermentation solutions to nutraceutical and functional food manufacturers worldwide. The division leverages extensive R&D capabilities to provide clinically documented solutions that modulate the human microbiome.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AB Biotek HNH.